Table of Contents
1 Study Coverage
1.1 Intravitreal (IVT) Injectables Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Type
1.4.2 Anti-VEGF
1.4.3 Corticosteroids
1.4.4 Antibiotics
1.4.5 Antivirals
1.4.6 Antifungals
1.5 Market by Application
1.5.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Mail Order Pharmacies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravitreal (IVT) Injectables Market Size
2.1.1 Global Intravitreal (IVT) Injectables Revenue 2014-2025
2.1.2 Global Intravitreal (IVT) Injectables Sales 2014-2025
2.2 Intravitreal (IVT) Injectables Growth Rate by Regions
2.2.1 Global Intravitreal (IVT) Injectables Sales by Regions
2.2.2 Global Intravitreal (IVT) Injectables Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Intravitreal (IVT) Injectables Sales by Manufacturers
3.1.1 Intravitreal (IVT) Injectables Sales by Manufacturers
3.1.2 Intravitreal (IVT) Injectables Sales Market Share by Manufacturers
3.2 Intravitreal (IVT) Injectables Revenue by Manufacturers
3.2.1 Intravitreal (IVT) Injectables Revenue by Manufacturers (2014-2019)
3.2.2 Intravitreal (IVT) Injectables Revenue Share by Manufacturers (2014-2019)
3.3 Intravitreal (IVT) Injectables Price by Manufacturers
3.4 Intravitreal (IVT) Injectables Manufacturing Base Distribution, Product Types
3.4.1 Intravitreal (IVT) Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravitreal (IVT) Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Intravitreal (IVT) Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Intravitreal (IVT) Injectables Sales by Type
4.2 Global Intravitreal (IVT) Injectables Revenue by Type
4.3 Intravitreal (IVT) Injectables Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Intravitreal (IVT) Injectables Breakdown Data by Application
6 North America
6.1 North America Intravitreal (IVT) Injectables by Country
6.1.1 North America Intravitreal (IVT) Injectables Sales by Country
6.1.2 North America Intravitreal (IVT) Injectables Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intravitreal (IVT) Injectables by Type
6.3 North America Intravitreal (IVT) Injectables by Application
7 Europe
7.1 Europe Intravitreal (IVT) Injectables by Country
7.1.1 Europe Intravitreal (IVT) Injectables Sales by Country
7.1.2 Europe Intravitreal (IVT) Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravitreal (IVT) Injectables by Type
7.3 Europe Intravitreal (IVT) Injectables by Application
8 Asia Pacific
8.1 Asia Pacific Intravitreal (IVT) Injectables by Region
8.1.1 Asia Pacific Intravitreal (IVT) Injectables Sales by Region
8.1.2 Asia Pacific Intravitreal (IVT) Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Intravitreal (IVT) Injectables by Type
8.3 Asia Pacific Intravitreal (IVT) Injectables by Application
9 Central & South America
9.1 Central & South America Intravitreal (IVT) Injectables by Country
9.1.1 Central & South America Intravitreal (IVT) Injectables Sales by Country
9.1.2 Central & South America Intravitreal (IVT) Injectables Revenue by Country
9.1.3 Brazil
9.2 Central & South America Intravitreal (IVT) Injectables by Type
9.3 Central & South America Intravitreal (IVT) Injectables by Application
10 Middle East and Africa
10.1 Middle East and Africa Intravitreal (IVT) Injectables by Country
10.1.1 Middle East and Africa Intravitreal (IVT) Injectables Sales by Country
10.1.2 Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intravitreal (IVT) Injectables by Type
10.3 Middle East and Africa Intravitreal (IVT) Injectables by Application
11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Products Offered
11.1.5 Regeneron Pharmaceuticals Recent Development
11.2 Bausch & Lomb
11.2.1 Bausch & Lomb Company Details
11.2.2 Company Business Overview
11.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Products Offered
11.2.5 Bausch & Lomb Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Intravitreal (IVT) Injectables Products Offered
11.3.5 Novartis Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Company Business Overview
11.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Allergan Intravitreal (IVT) Injectables Products Offered
11.4.5 Allergan Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Company Business Overview
11.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Alimera Sciences Intravitreal (IVT) Injectables Products Offered
11.5.5 Alimera Sciences Recent Development
11.6 ThromboGenics
11.6.1 ThromboGenics Company Details
11.6.2 Company Business Overview
11.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.6.4 ThromboGenics Intravitreal (IVT) Injectables Products Offered
11.6.5 ThromboGenics Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Company Business Overview
11.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
12 Future Forecast
12.1 Intravitreal (IVT) Injectables Market Forecast by Regions
12.1.1 Global Intravitreal (IVT) Injectables Sales Forecast by Regions 2019-2025
12.1.2 Global Intravitreal (IVT) Injectables Revenue Forecast by Regions 2019-2025
12.2 Intravitreal (IVT) Injectables Market Forecast by Type
12.2.1 Global Intravitreal (IVT) Injectables Sales Forecast by Type 2019-2025
12.2.2 Global Intravitreal (IVT) Injectables Revenue Forecast by Type 2019-2025
12.3 Intravitreal (IVT) Injectables Market Forecast by Application
12.4 North America Intravitreal (IVT) Injectables Forecast
12.5 Europe Intravitreal (IVT) Injectables Forecast
12.6 Asia Pacific Intravitreal (IVT) Injectables Forecast
12.7 Central & South America Intravitreal (IVT) Injectables Forecast
12.8 Middle East and Africa Intravitreal (IVT) Injectables Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravitreal (IVT) Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Regeneron Pharmaceuticals、Bausch & Lomb、Novartis、Allergan、Alimera Sciences、ThromboGenics、Bristol-Myers Squibb
【免責事項】
https://www.globalresearch.jp/disclaimer